Cullinan Oncology, Inc. (CGEM) Tops Q3 EPS by 43c

Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q3 EPS of ($0.54), $0.43 better than the analyst estimate of ($0.97). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• General Mills (GIS) PT Lowered to $42 at Freedom Broker
• AI chip winners may face tougher road ahead as hyperscalers catch up: JPM